Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6196 AL 6210

Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection

Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A.

Cell Tissue Res. 2012 Jan;347(1):291-301. doi: 10.1007/s00441-011-1230-6. Epub 2011 Aug 31.

'Clinical trials in Alzheimer's disease': immunotherapy approaches

Delrieu J, Ousset PJ, Caillaud C, Vellas B.

J Neurochem. 2012 Jan;120 Suppl 1:186-193. doi: 10.1111/j.1471-4159.2011.07458.x. Epub 2011 Nov 28.

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

Chen S, Liu AR, An FM, Yao WB, Gao XD.

Age (Dordr). 2012 Oct;34(5):1211-24. doi: 10.1007/s11357-011-9303-8. Epub 2011 Sep 8.

Strategic role for mitochondria in Alzheimer's disease and cancer

Hedskog L, Zhang S, Ankarcrona M.

Antioxid Redox Signal. 2012 Jun 15;16(12):1476-91. doi: 10.1089/ars.2011.4259. Epub 2011 Oct 26.

Selective liver X receptor modulators (SLiMs): what use in human health?

Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro JM, Baron S.

Mol Cell Endocrinol. 2012 Apr 4;351(2):129-41. doi: 10.1016/j.mce.2011.08.036. Epub 2011 Sep 1.

[Pharmacological and clinical profiles of galantamine (Reminyl(®))]

Nagino K, Shikinami K, Saito T, Harada Y.

Nihon Yakurigaku Zasshi. 2011 Sep;138(3):122-6. doi: 10.1254/fpj.138.122.

Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease

Guan JZ, Guan WP, Maeda T, Makino N.

Gerontology. 2012;58(1):62-9. doi: 10.1159/000327821. Epub 2011 Sep 7.

Chronic divalproex sodium use and brain atrophy in Alzheimer disease

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14.

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine

Anekonda TS, Quinn JF.

Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. doi: 10.1016/j.bbadis.2011.08.013. Epub 2011 Sep 8.

Therapeutic compliance of nanomedicine in Alzheimer's disease

Wilson B.

Nanomedicine (Lond). 2011 Sep;6(7):1137-9. doi: 10.2217/nnm.11.114.

Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease

Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T.

Geriatr Gerontol Int. 2012 Apr;12(2):207-14. doi: 10.1111/j.1447-0594.2011.00746.x. Epub 2011 Sep 19.

Antioxidant pathways in Alzheimer's disease: possibilities of intervention

Viña J, Lloret A, Giraldo E, Badia MC, Alonso MD.

Curr Pharm Des. 2011 Dec;17(35):3861-4. doi: 10.2174/138161211798357755.

Use of memantine for the treatment of dementia

Lo D, Grossberg GT.

Expert Rev Neurother. 2011 Oct;11(10):1359-70. doi: 10.1586/ern.11.132.

New developments on the role of NMDA receptors in Alzheimer's disease

Malinow R.

Curr Opin Neurobiol. 2012 Jun;22(3):559-63. doi: 10.1016/j.conb.2011.09.001. Epub 2011 Sep 29.

A review of the effects of memantine on clinical progression in Alzheimer's disease

Wilkinson D.

Int J Geriatr Psychiatry. 2012 Aug;27(8):769-76. doi: 10.1002/gps.2788. Epub 2011 Oct 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias